BRAINSTORM CELL THERAPEUTICSCS INC
BRAINSTORM CELL THERAPEUTICSCS INC
Action · US10501E2019 · BCLI · A12BXW (XNCM)
Aperçu Indicateurs financiers
1,19 USD
8,18 % 0,09 USD
NASDAQ CAPITAL MARKET (XNAS) · Cours et graphiques actuels sur MoneyPeak
06.06.2025 23:14

Cours actuels de BRAINSTORM CELL THERAPEUTICSCS INC

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
BCLI
USD
06.06.2025 23:14
1,19 USD
1,13 USD
+5,78 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 8,18 % -1,65 % -25,62 % -25,16 % -80,80 % -99,13 %

Profil de l'entreprise pour BRAINSTORM CELL THERAPEUTICSCS INC Action

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; and Phase II clinical trial for the treatment of progressive multiple sclerosis and alzheimer's disease, as well as for other neurodegenerative diseases. The company has a partnership with Catalent for manufacturing NurOwn. The company was formerly known as Golden Hand Resources Inc. and changed its name to Brainstorm Cell Therapeutics Inc. in November 2004. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

Données de l'entreprise

Nom BRAINSTORM CELL THERAPEUTICSCS INC
Société Brainstorm Cell Therapeutics Inc.
Symbole BCLI
Site web https://www.brainstorm-cell.com
Marché d'origine XNCM NASDAQ CAPITAL MARKET
WKN A12BXW
ISIN US10501E2019
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Chaim Lebovits
Pays États-Unis d'Amérique
Devise USD
Employés 0,0 T
Adresse 1325 Avenue of Americas, 10019 New York
Date d'introduction en bourse 2003-10-07

Fractionnements d'actions

Date Fractionnement
01.10.2024 1:15
16.09.2014 1:15

Symboles boursiers

Nom Symbole
Frankfurt GHDN.F
NASDAQ BCLI

Autres actions

Les investisseurs qui détiennent BRAINSTORM CELL THERAPEUTICSCS INC ont également les actions suivantes dans leur portefeuille :
AMGEN INC
AMGEN INC Action
AUTODESK INC
AUTODESK INC Action
CISCO SYSTEMS INC
CISCO SYSTEMS INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
DEXCO INC
DEXCO INC Action
FIRST FINANCIAL NORTHWEST INC
FIRST FINANCIAL NORTHWEST INC Action
INTEL CORP
INTEL CORP Action
INTUITIVE SURGICAL INC
INTUITIVE SURGICAL INC Action
LB.HESS.THR.CARRARA11ZA/1
LB.HESS.THR.CARRARA11ZA/1 Obligation
LYXOR ETF SG GLOBAL QUALITY INCOME NTR
LYXOR ETF SG GLOBAL QUALITY INCOME NTR ETF
MICROSOFT CORP
MICROSOFT CORP Action
NETFLIX INC
NETFLIX INC Action
Nickel
Nickel Matières premières
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025